benzonidazole has been researched along with Thrombophilia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Padilla, J; Cortes-Serra, N; Gascon, J; Pinazo, MJ; Reverter, JC; Tassies, D | 1 |
| Abras, A; Aldasoro, E; de Almeida, IC; de Lazzari, E; Gallego, M; Gascon, J; Izquierdo, L; Marques, AF; Muñoz, J; Pinazo, MJ; Posada, Ede J; Reverter, JC; Tassies, D; Tebar, S | 1 |
| Ayala, E; Fisa, R; Gállego, M; Gascon, J; Monteagudo, J; Muñoz, J; Pinazo, MJ; Posada, Ede J; Reverter, JC; Tàssies, D | 1 |
3 other study(ies) available for benzonidazole and Thrombophilia
| Article | Year |
|---|---|
Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma.
Topics: Biomarkers; Chagas Disease; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Humans; Nitroimidazoles; Prognosis; Thrombin; Thrombophilia; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.
Topics: Adolescent; Adult; Antiprotozoal Agents; Biomarkers; Chagas Disease; Chronic Disease; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Thrombophilia; Treatment Outcome; Young Adult | 2016 |
Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients.
Topics: Adult; Biomarkers; Biomarkers, Pharmacological; Chagas Disease; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prothrombin; Risk; Thrombin; Thromboembolism; Thrombophilia; Trypanosoma cruzi | 2011 |